"On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Flu infections"...
Inform vaccine recipients of the potential benefits and risks of immunization with FLUCELVAX.
Educate vaccine recipients regarding the potential side effects; clinicians should emphasize that (1) FLUCELVAX contains non-infectious particles and cannot cause influenza and (2) FLUCELVAX is intended to provide protection against illness due to influenza viruses only, and cannot provide protection against other respiratory illnesses.
Instruct vaccine recipients to report adverse reactions to their healthcare provider.
Provide vaccine recipients with the Vaccine Information Statements which are required by the National Childhood Vaccine Injury Act of 1986. These materials are available free of charge at the Centers for Disease Control and Prevention (CDC) website (www.cdc.gov/vaccines).
Inform vaccine recipients that annual vaccination is recommended.
Last reviewed on RxList: 10/15/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Flucelvax Information
Report Problems to the Food and Drug Administration
Find out what women really need.